Bong Chul Chu

Bong Chul Chu has more than 17 years of experience in the field, with a diverse range of roles and responsibilities. Bong Chul currently holds the position of Director, Biostatistics (Medical Affairs, RWE) at GRAIL, Inc., a position they have held since January 2022. Prior to this, they served as Associate Director, Biostatistics (Medical Affairs, RWE) at GRAIL, Inc. From May 2020 to November 2020, they worked as an Associate Director, Real World Evidence at Genesis Research. Bong Chul also held the role of Associate Director, Epidemiology at Gilead Sciences from May 2019 to May 2020. Before that, they served as Principal Biostatistician (Director Level), Real World Evidence at Evidera from March 2017 to May 2019. Bong Chul Chu started their career at IBM Watson Health as a Senior Biostatistician, HEOR, where they worked from October 2005 to March 2017. Prior to that, they gained experience as a Research Scientist at the Pacific Institute for Research and Evaluation from June 2004 to September 2005. Bong Chul began their professional journey as a Postdoctoral Fellow at Rutgers New Jersey Medical School from September 2003 to May 2004.

Bong Chul Chu pursued their education in the field of health services and research. Bong Chul began their academic journey in 1997 at Washington University in St. Louis, where they pursued a Master's degree in Health Services Administration. Bong Chul successfully completed this program in 1999. Following this, Bong Chul Chu enrolled at Saint Louis University and embarked on a Ph.D. program in Health Services Research, specializing in Biostatistics & Epidemiology. Bong Chul dedicated four years to this program, from 1999 to 2003, and successfully obtained their doctoral degree.